Glucagon-like peptide receptor agonists and risk for depression

9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Medical Care in Diabetes—2022</i>

Diabetes Care · 2021 · 1.5K citations

Medicine, Pharmacotherapy, Clinical Pharmacology +13

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

Aaron S. Kelly, Pernille Auerbach, Margarita Barrientos‐Pérez et al. · New England Journal of Medicine · 2020 · 669 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +17

Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials

Patrick M. O’Neil, Vanita R. Aroda, Arne Astrup et al. · Diabetes Obesity and Metabolism · 2017 · 112 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Patient‐reported outcomes following treatment with the human GLP‐1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes

Bruce W. Bode, Marcia A. Testa, Melissa Magwire et al. · Diabetes Obesity and Metabolism · 2010 · 75 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Psychological and quality of life changes in patients using GLP-1 analogues

Paul Grant, David Lipscomb, John Quin · Journal of Diabetes and its Complications · 2011 · 74 citations

Pharmacy, Pharmacology, Psychology +12